These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 16901517)
1. Blockade of group II metabotropic glutamate receptors in the nucleus accumbens produces hyperlocomotion in rats previously exposed to amphetamine. Chi H; Jang JK; Kim JH; Vezina P Neuropharmacology; 2006 Oct; 51(5):986-92. PubMed ID: 16901517 [TBL] [Abstract][Full Text] [Related]
2. The metabotropic glutamate receptor antagonist (RS)-MCPG produces hyperlocomotion in amphetamine pre-exposed rats. Kim JH; Vezina P Neuropharmacology; 1998; 37(2):189-97. PubMed ID: 9680243 [TBL] [Abstract][Full Text] [Related]
3. Blockade of group II metabotropic glutamate receptors produces hyper-locomotion in cocaine pre-exposed rats by interactions with dopamine receptors. Yoon HS; Jang JK; Kim JH Neuropharmacology; 2008 Sep; 55(4):555-9. PubMed ID: 18675831 [TBL] [Abstract][Full Text] [Related]
4. Blockade of group II, but not group I, mGluRs in the rat nucleus accumbens inhibits the expression of conditioned hyperactivity in an amphetamine-associated environment. Kim WY; Vezina P; Kim JH Behav Brain Res; 2008 Aug; 191(1):62-6. PubMed ID: 18433894 [TBL] [Abstract][Full Text] [Related]
5. Activation of group II mGlu receptors blocks the enhanced drug taking induced by previous exposure to amphetamine. Kim JH; Austin JD; Tanabe L; Creekmore E; Vezina P Eur J Neurosci; 2005 Jan; 21(1):295-300. PubMed ID: 15654869 [TBL] [Abstract][Full Text] [Related]
6. Place preference induced by nucleus accumbens amphetamine is impaired by local blockade of Group II metabotropic glutamate receptors in rats. Gerdjikov TV; Beninger RJ BMC Neurosci; 2006 May; 7():43. PubMed ID: 16734896 [TBL] [Abstract][Full Text] [Related]
7. Group II, but not group I, metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. Kim JH; Beeler JA; Vezina P Neuropharmacology; 2000 Jul; 39(10):1692-9. PubMed ID: 10884551 [TBL] [Abstract][Full Text] [Related]
8. The mGlu2/3 receptor agonist LY379268 blocks the expression of locomotor sensitization by amphetamine. Kim JH; Vezina P Pharmacol Biochem Behav; 2002 Sep; 73(2):333-7. PubMed ID: 12117587 [TBL] [Abstract][Full Text] [Related]
9. Blockade of the locomotor stimulant effects of amphetamine by group I, group II, and group III metabotropic glutamate receptor ligands in the rat nucleus accumbens: possible interactions with dopamine receptors. David HN; Abraini JH Neuropharmacology; 2003 May; 44(6):717-27. PubMed ID: 12681370 [TBL] [Abstract][Full Text] [Related]
11. Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area. Vezina P; Queen AL Psychopharmacology (Berl); 2000 Aug; 151(2-3):184-91. PubMed ID: 10972464 [TBL] [Abstract][Full Text] [Related]
12. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration. Mao L; Wang JQ Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936 [TBL] [Abstract][Full Text] [Related]
13. Activation of metabotropic glutamate receptors in the rat nucleus accumbens increases locomotor activity in a dopamine-dependent manner. Kim JH; Vezina P J Pharmacol Exp Ther; 1997 Nov; 283(2):962-8. PubMed ID: 9353420 [TBL] [Abstract][Full Text] [Related]
14. Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. Kim JH; Vezina P J Pharmacol Exp Ther; 1998 Jan; 284(1):317-22. PubMed ID: 9435194 [TBL] [Abstract][Full Text] [Related]
15. Regulation of Akt and Wnt signaling by the group II metabotropic glutamate receptor antagonist LY341495 and agonist LY379268. Sutton LP; Rushlow WJ J Neurochem; 2011 Jun; 117(6):973-83. PubMed ID: 21477044 [TBL] [Abstract][Full Text] [Related]
16. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats. Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637 [TBL] [Abstract][Full Text] [Related]
17. Chronic microinjection of valproic acid into the nucleus accumbens attenuates amphetamine-induced locomotor activity. Kim WY; Kim S; Kim JH Neurosci Lett; 2008 Feb; 432(1):54-7. PubMed ID: 18164815 [TBL] [Abstract][Full Text] [Related]
18. Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice. O'Neill MF; Heron-Maxwell C; Conway MW; Monn JA; Ornstein P Neuropharmacology; 2003 Oct; 45(5):565-74. PubMed ID: 12941370 [TBL] [Abstract][Full Text] [Related]
19. Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell. Greenslade RG; Mitchell SN Neuropharmacology; 2004 Jul; 47(1):1-8. PubMed ID: 15165829 [TBL] [Abstract][Full Text] [Related]
20. Amygdala group II mGluRs mediate the inhibitory effects of systemic group II mGluR activation on behavior and spinal neurons in a rat model of arthritis pain. Mazzitelli M; Neugebauer V Neuropharmacology; 2019 Nov; 158():107706. PubMed ID: 31306647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]